SLC12A1
SLC12A1 (solute carrier family 12 member 1, also known as NKCC2, CCC2, BSC1, BSC and BSC-1) is a kidney-specific sodium-potassium-chloride cotransporter. It mediates transepithelial NaCl reabsorption in the thick ascending limb and contributes to urinary concentration and volume regulation. Browse Assay Genie's current range of SLC12A1 research reagents below, or read on for the biology behind the target.
SLC12A1 is a renal sodium, potassium and chloride non-electrogenic ion symporter. It mediates transepithelial NaCl reabsorption in the thick ascending limb of the nephron and plays an essential role in urinary concentration and volume regulation. The transporter can also substitute NH4(+) for K(+), which enables apical transmembrane transport of ammonium in the medullary thick ascending limb. This activity is important for ammonium homeostasis in the kidney, particularly during metabolic acidosis.
The SLC12A1 gene encodes a kidney-specific cotransporter that is expressed on the luminal (apical) membrane of renal epithelial cells in the thick ascending limb of Henle's loop and in the macula densa. It accounts for most of the NaCl resorption in this segment and is sensitive to loop diuretics such as furosemide and bumetanide. The protein belongs to the SLC12A transporter family, within the HGNC solute carrier family 12 gene group. Alternative splicing of the gene produces multiple transcript variants encoding distinct isoforms, although the biological validity of some additional splice variants in humans has not been experimentally proven.
The protein is widely referred to as NKCC2, and the aliases CCC2, BSC1, BSC and BSC-1 are also in use. The earlier HGNC name was solute carrier family 12 (sodium/potassium/chloride transporter), member 1. Defects in the SLC12A1 gene underlie some Bartter-like syndromes, which makes it a central target for studies of renal salt handling and diuretic pharmacology.
SLC12A1 drives NaCl reabsorption in the thick ascending limb, making it a core protein for studying urinary concentration and volume regulation.
The transporter is sensitive to loop diuretics such as furosemide and bumetanide, so it is a key subject in studies of their mechanism.
Defects in the SLC12A1 gene cause some Bartter-like syndromes, supporting genetic and functional work on inherited renal salt-wasting disorders.
By substituting NH4(+) for K(+), SLC12A1 supports renal ammonium homeostasis, particularly during metabolic acidosis.
SLC12A1 is a non-electrogenic sodium, potassium and chloride symporter in the kidney. It mediates transepithelial NaCl reabsorption in the thick ascending limb and is essential for urinary concentration and volume regulation. It can also carry NH4(+) in place of K(+), supporting ammonium homeostasis.
Yes. NKCC2 is the common name for the protein encoded by the SLC12A1 gene. Other aliases include CCC2, BSC1, BSC and BSC-1. The gene was previously named solute carrier family 12 (sodium/potassium/chloride transporter), member 1, and alternative splicing yields multiple isoforms.
Mouse and rat both have a Slc12a1 ortholog. In humans, defects in SLC12A1 cause some Bartter-like syndromes. Check the datasheet of any product for its validated reactivity.
Other SLC12A family cotransporters and solute carriers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13621; product specifications from Assay Genie datasheets.